2.93  -0.19 (-6.09%)		01-17 16:00
Open: 3.12 High: 3.2993 Volume: 279,435		Pre. Close: 3.12 Low: 2.3669 Market Cap: 8(M)

Short term
Mid term
Targets	6-month :	10.98	1-year :	16.05
Resists	First :	9.4	Second :	13.75
Pivot price	7.04
Supports	First :	2.36	Second :	1.96
MAs	MA(5) :	3.14	MA(20) :	7.37
	MA(100) :	13.26	MA(250) :	33.55
MACD	MACD :	-2	Signal :	-1.5
%K %D	K(14,3) :	5.4	D(3) :	5
RSI	RSI(14): 27.8
52-week	High :	98.75	Low :	2.36

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ALUR ] has closed above bottom band by 18.9%. Bollinger Bands are 155.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	3.3 - 3.32	3.32 - 3.34
Low:	2.34 - 2.35	2.35 - 2.36
Close:	2.9 - 2.93	2.93 - 2.96

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Thu, 16 Jan 2025
RTW INVESTMENTS, LP Acquires Additional Shares in Allurion Techn - GuruFocus.com

Tue, 14 Jan 2025
Allurion Announces Private Placement of Common Stock and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024 - Business Wire

Tue, 14 Jan 2025
Allurion Technologies Secures $2.5M Investment, Reports $32M Revenue Meeting 2024 Guidance - StockTitan

Fri, 10 Jan 2025
RTW INVESTMENTS, LP Acquires Additional Shares in Allurion Techn - GuruFocus.com

Fri, 03 Jan 2025
Allurion Technologies (NYSE:ALUR) Sees Unusually-High Trading Volume - Time to Buy? - MarketBeat

Tue, 24 Dec 2024
Allurion Technologies announces reverse stock split - Investing.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NYSE
Sector: Healthcare
Industry: Medical - Devices
Shares Out	3 (M)
Shares Float	39 (M)
Held by Insiders	20.8 (%)
Held by Institutions	126.8 (%)
Shares Short	42 (K)
Shares Short P.Month	36 (K)

EPS	-10.25
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-1.01
Profit Margin	-71.3 %
Operating Margin	-230 %
Return on Assets (ttm)	-43 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	-70.5 %
Gross Profit (p.s.)	0
Sales Per Share	12.82
EBITDA (p.s.)	-21.42
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	-0.29
PEG Ratio	0
Price to Book value	-2.91
Price to Sales	0.22
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.